O'Keefe Stevens Advisory’s Bristol-Myers Squibb BMY Stock Holding History

O'Keefe Stevens Advisory’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$260K	Hold	4,170	–	–	0.05%	70
2026 Q2	$240K	Hold	4,170	–	–	0.05%	74
2026 Q1	$253K	Hold	4,170	–	–	0.06%	67
2025 Q4	$225K	Buy	+4,170	New	+$201K	0.06%	63
2025 Q2	–	Sell	-4,632	Closed	-$283K	–	69
2025 Q1	$283K	Buy	4,632 +62	+1%	+$3.61K	0.09%	59
2024 Q4	$258K	Hold	4,570	–	–	0.08%	64
2024 Q3	$236K	Buy	+4,570	New	+$214K	0.07%	66
2024 Q2	–	Sell	-4,570	Closed	-$248K	–	70
2024 Q1	$248K	Hold	4,570	–	–	0.08%	51
2023 Q4	$234K	Buy	+4,570	New	+$240K	0.09%	41

Other funds holding BMY

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

M&G plc London, United Kingdom $19.9B AUM 15.09% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

O'Keefe Stevens Advisory's BMY Position: Q3 2026 in Review

O'Keefe Stevens Advisory held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 4,170 shares worth $260K. The position accounts for 0.05% of the portfolio, ranked #70.

O'Keefe Stevens Advisory first reported a position in BMY in Q4 2023 and has held it in 9 quarters since. The position peaked at $283K in Q1 2025. 1,436 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

O'Keefe Stevens Advisory held 4,170 shares of Bristol-Myers Squibb worth $260K as of Q3 2026.
O'Keefe Stevens Advisory left its Bristol-Myers Squibb share count unchanged in Q3 2026.
Bristol-Myers Squibb made up 0.05% of O'Keefe Stevens Advisory's portfolio in Q3 2026, its #70 holding.
O'Keefe Stevens Advisory first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 9 quarters since.
O'Keefe Stevens Advisory's Bristol-Myers Squibb position peaked at $283K in Q1 2025.
1,436 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on O'Keefe Stevens Advisory's 13F filing for Q3 2026, filed 9 Oct 2026.